171 related articles for article (PubMed ID: 37450699)
21. Crosstalk between Beclin-1-dependent autophagy and caspase‑dependent apoptosis induced by tanshinone IIA in human osteosarcoma MG-63 cells.
Ma K; Zhang C; Huang MY; Guo YX; Hu GQ
Oncol Rep; 2016 Oct; 36(4):1807-18. PubMed ID: 27499329
[TBL] [Abstract][Full Text] [Related]
22. Fisetin, a phytopolyphenol, targets apoptotic and necroptotic cell death in HepG2 cells.
Sundarraj K; Raghunath A; Panneerselvam L; Perumal E
Biofactors; 2020 Jan; 46(1):118-135. PubMed ID: 31634424
[TBL] [Abstract][Full Text] [Related]
23. Isoorientin induces apoptosis and autophagy simultaneously by reactive oxygen species (ROS)-related p53, PI3K/Akt, JNK, and p38 signaling pathways in HepG2 cancer cells.
Yuan L; Wei S; Wang J; Liu X
J Agric Food Chem; 2014 Jun; 62(23):5390-400. PubMed ID: 24841907
[TBL] [Abstract][Full Text] [Related]
24. Isodeoxyelephantopin induces protective autophagy in lung cancer cells via Nrf2-p62-keap1 feedback loop.
Wang Y; Zhang J; Huang ZH; Huang XH; Zheng WB; Yin XF; Li YL; Li B; He QY
Cell Death Dis; 2017 Jun; 8(6):e2876. PubMed ID: 28617433
[TBL] [Abstract][Full Text] [Related]
25. Fisetin inhibits cellular proliferation and induces mitochondria-dependent apoptosis in human gastric cancer cells.
Sabarwal A; Agarwal R; Singh RP
Mol Carcinog; 2017 Feb; 56(2):499-514. PubMed ID: 27254419
[TBL] [Abstract][Full Text] [Related]
26. Gene augmented nuclear-targeting sonodynamic therapy via Nrf2 pathway-based redox balance adjustment boosts peptide-based anti-PD-L1 therapy on colorectal cancer.
Wan G; Chen X; Wang H; Hou S; Wang Q; Cheng Y; Chen Q; Lv Y; Chen H; Zhang Q
J Nanobiotechnology; 2021 Oct; 19(1):347. PubMed ID: 34715867
[TBL] [Abstract][Full Text] [Related]
27. Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells.
He G; Feng C; Vinothkumar R; Chen W; Dai X; Chen X; Ye Q; Qiu C; Zhou H; Wang Y; Liang G; Xie Y; Wu W
Cancer Chemother Pharmacol; 2016 Dec; 78(6):1151-1161. PubMed ID: 27787644
[TBL] [Abstract][Full Text] [Related]
28. Autophagy assuages myocardial infarction through Nrf2 signaling activation-mediated reactive oxygen species clear.
Sun B; Xu Y; Liu ZY; Meng WX; Yang H
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7381-7390. PubMed ID: 32706077
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of Nrf2 enhances autophagy induced by temozolomide in U251 human glioma cell line.
Zhou Y; Wang HD; Zhu L; Cong ZX; Li N; Ji XJ; Pan H; Wang JW; Li WC
Oncol Rep; 2013 Jan; 29(1):394-400. PubMed ID: 23128449
[TBL] [Abstract][Full Text] [Related]
30. Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling.
Chang CH; Lee CY; Lu CC; Tsai FJ; Hsu YM; Tsao JW; Juan YN; Chiu HY; Yang JS; Wang CC
Int J Oncol; 2017 Mar; 50(3):873-882. PubMed ID: 28197628
[TBL] [Abstract][Full Text] [Related]
31. Nrf2 promotes progression of non-small cell lung cancer through activating autophagy.
Wang J; Liu Z; Hu T; Han L; Yu S; Yao Y; Ruan Z; Tian T; Huang T; Wang M; Jing L; Nan K; Liang X
Cell Cycle; 2017 Jun; 16(11):1053-1062. PubMed ID: 28402166
[TBL] [Abstract][Full Text] [Related]
32. EBV reduces autophagy, intracellular ROS and mitochondria to impair monocyte survival and differentiation.
Gilardini Montani MS; Santarelli R; Granato M; Gonnella R; Torrisi MR; Faggioni A; Cirone M
Autophagy; 2019 Apr; 15(4):652-667. PubMed ID: 30324853
[TBL] [Abstract][Full Text] [Related]
33. Abrus agglutinin inhibits oral carcinogenesis through inactivation of NRF2 signaling pathway.
Panigrahi DP; Bhol CS; R N; Nagini S; Patil S; Maiti TK; Bhutia SK
Int J Biol Macromol; 2020 Jul; 155():1123-1132. PubMed ID: 31715238
[TBL] [Abstract][Full Text] [Related]
34. TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling.
Liu W; Zhao Y; Wang G; Feng S; Ge X; Ye W; Wang Z; Zhu Y; Cai W; Bai J; Zhou X
Redox Biol; 2022 Jul; 53():102344. PubMed ID: 35636015
[TBL] [Abstract][Full Text] [Related]
35. Hwang-Heuk-San induces apoptosis in HCT116 human colorectal cancer cells through the ROS-mediated activation of caspases and the inactivation of the PI3K/Akt signaling pathway.
Lee MH; Hong SH; Park C; Kim GY; Leem SH; Choi SH; Keum YS; Hyun JW; Kwon TK; Hong SH; Choi YH
Oncol Rep; 2016 Jul; 36(1):205-14. PubMed ID: 27221553
[TBL] [Abstract][Full Text] [Related]
36. A novel coordination complex of platinum (PT) induces cell death in colorectal cancer by altering redox balance and modulating MAPK pathway.
Al-Khayal K; Vaali-Mohammed MA; Elwatidy M; Bin Traiki T; Al-Obeed O; Azam M; Khan Z; Abdulla M; Ahmad R
BMC Cancer; 2020 Jul; 20(1):685. PubMed ID: 32703189
[TBL] [Abstract][Full Text] [Related]
37. α-hederin induces autophagic cell death in colorectal cancer cells through reactive oxygen species dependent AMPK/mTOR signaling pathway activation.
Sun J; Feng Y; Wang Y; Ji Q; Cai G; Shi L; Wang Y; Huang Y; Zhang J; Li Q
Int J Oncol; 2019 May; 54(5):1601-1612. PubMed ID: 30896843
[TBL] [Abstract][Full Text] [Related]
38. Novel derivative of aminobenzenesulfonamide (3c) induces apoptosis in colorectal cancer cells through ROS generation and inhibits cell migration.
Al-Khayal K; Alafeefy A; Vaali-Mohammed MA; Mahmood A; Zubaidi A; Al-Obeed O; Khan Z; Abdulla M; Ahmad R
BMC Cancer; 2017 Jan; 17(1):4. PubMed ID: 28049506
[TBL] [Abstract][Full Text] [Related]
39. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
40. TRAIL attenuates sulforaphane-mediated Nrf2 and sustains ROS generation, leading to apoptosis of TRAIL-resistant human bladder cancer cells.
Jin CY; Molagoda IMN; Karunarathne WAHM; Kang SH; Park C; Kim GY; Choi YH
Toxicol Appl Pharmacol; 2018 Aug; 352():132-141. PubMed ID: 29792947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
